130 results
S-8
EX-99.2
NTBL
Notable Labs Ltd
19 Apr 24
Registration of securities for employees
4:56pm
.
Term of Options; Exercise.
Reserved.
Taxation.
Rights as a Shareholder; Dividends.
Rights and/or Benefits arising out of the Employee/Employer … ) or with respect to dividends or any other benefits in respect thereof (“Withholding Tax”), and to make payment (or to reimburse itself or himself
8-K
EX-99.1
NTBL
Notable Labs Ltd
12 Apr 24
Notable Labs Reports 2023 Financial Results and Provides a Business Update
8:44am
to, express or implied statements regarding Notable’s future operations and goals; the potential benefits of any therapeutic candidates or platform … to the Israel-Hamas war; (ix) Notable’s ability to obtain orphan drug designation, and the associated benefits, for any of its drug candidates; (x
8-K
EX-99.1
xuk7z
9 Apr 24
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
5:20pm
8-K
EX-99.1
s6popn5yotd7a
8 Apr 24
Other Events
12:15pm
8-K
EX-99.1
i48dz0kdsuzz9r2v
22 Feb 24
Other Events
8:15am
DEF 14A
rhazvt
16 Feb 24
Definitive proxy
9:00am
PRE 14A
rpt k9gdi
5 Feb 24
Preliminary proxy
5:00pm
8-K
EX-99.1
qar64l
18 Dec 23
Other Events
8:15am
8-K/A
EX-99.3
cpexzsan89pab
29 Nov 23
Financial Statements and Exhibits
5:15pm
8-K/A
EX-99.3
s6mmph8qb9s jc
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K/A
EX-99.2
u30w9cnpv
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K
EX-99.1
803u vkotiep2b908
14 Nov 23
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
12:00am
S-3
EX-3.1
cncea 886
17 Oct 23
Shelf registration
5:01pm
8-K
3zrvic h61x9
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-99.1
98y4yqlxpodbjwx
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
425
6mrn8
4 Oct 23
Business combination disclosure
4:33pm